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Abstract
The human ovary contains a fixed number of non-growing follicles (NGFs) established before birth that decline with
increasing age culminating in the menopause at 50–51 years. The objective of this study is to model the age-related
population of NGFs in the human ovary from conception to menopause. Data were taken from eight separate quantitative
histological studies (n=325) in which NGF populations at known ages from seven weeks post conception to 51 years
(median 32 years) were calculated. The data set was fitted to 20 peak function models, with the results ranked by obtained
r2 correlation coefficient. The highest ranked model was chosen. Our model matches the log-adjusted NGF population from
conception to menopause to a five-parameter asymmetric double Gaussian cumulative (ADC) curve (r2 =0.81). When
restricted to ages up to 25 years, the ADC curve has r2 =0.95. We estimate that for 95% of women by the age of 30 years
only 12% of their maximum pre-birth NGF population is present and by the age of 40 years only 3% remains. Furthermore,
we found that the rate of NGF recruitment towards maturation for most women increases from birth until approximately
age 14 years then decreases towards the menopause. To our knowledge, this is the first model of ovarian reserve from
conception to menopause. This model allows us to estimate the number of NGFs present in the ovary at any given age,
suggests that 81% of the variance in NGF populations is due to age alone, and shows for the first time, to our knowledge,
that the rate of NGF recruitment increases from birth to age 14 years then declines with age until menopause. An increased
understanding of the dynamics of human ovarian reserve will provide a more scientific basis for fertility counselling for both
healthy women and those who have survived gonadotoxic cancer treatments.
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Introduction
Our current understanding of human ovarian reserve presumes
that the ovary establishes several million non growing follicles
(NGFs) at around five months of gestational age which is followed
by a decline to the menopause when approximately 1,000 remain
at an average age of 50–51 years [1,2]. With approximately 450
ovulatory monthly cycles in the normal human reproductive
lifespan, this progressive decline in NGF numbers is attributed to
follicle death by apoptosis.
A number of recent reports have challenged this long held
understanding of mammalian reproductive biology by reporting
the presence of mitotically-active germ stem cells in juvenile and
adult mouse ovaries [3–5]. While the presence of germ stem cells
within the mammalian ovary that are capable of neo-oogenesis
remains controversial [6,7], a better understanding of the
establishment and decline of the NGF population will be
important in determining if neo-oogenesis occurs as part of
normal human physiological ageing.
Several studies have reported the number of NGFs at different
ages in humans [8–15] and constructed mathematical models of
NGF decline [1,2,13]. Some of these studies have suggested that
the instantaneous rate of temporal change increases around the
age of 37 years, when approximately 25,000 follicles remain,
followed by exhaustion of the NGF pool and menopause 12–14
years later [11,12]. These studies have addressed the decline from
birth of the NGF population, but none has included the crucial
establishment phase from conception to a peak at 18–22 weeks
gestation. Our study uses more histological data than any previous
study, and includes data from prenatal ovaries, allowing us to
analyse complete models involving both population establishment
and decline. The objective of our study is to identify the most
robust mathematical model to describe the establishment and
decline of NGFs in the human ovary from conception to
menopause. This will allow us to estimate the number of NGFs
present at a given age and describe the rate of recruitment of
NGFs towards maturation or apoptosis with increasing age.
Results
The Best Fitting Peak Model
The highest ranked model (r2 =0.81) returned by the search for
the best fitting model to the 325 data-points was a 5-parameter
asymmetric double-Gaussian cumulative (ADC) curve (Equation
(1)). The first 3 parameters, (a, b and c) define the scale and
amplitude of the curve; the remaining parameters (d and e) define
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The values for the parameters that maximise the r2 corre-
lation coefficient for our dataset are given in Equation (2). The
model is asymmetric, since rapid establishment is followed by a
long period of decline (d is small and e is large); it is double-
Gaussian cumulative since it is the product of two Gauss-error
functions.
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This model (illustrated graphically in Figure 1) demonstrates
that 81% of the variation in individual NGF populations is due to
age alone. Full statistical analysis and derivation details for the
model are given in additional file 1. Interestingly, if we confine our
analysis to the histological data from conception to age 25 years we
discover that the ADC model remains the best fit (r2 =0.95) and
that 95% of the variation in NGF numbers is due to age alone
(Figure 2).
To guard against model selection bias and to test the robustness
of the model with respect to the data, we randomly removed 50
data points 61 times and re-fitted the models, with the ADC model
being, on average, the best fitting model (double-sided t-test for
difference of means, p~0:0065). Additional file 2 gives details of
the statistical tests performed.
Models That Allow Neo-Oogenesis
To examine whether a model that permits neo-oogenesis would
provide a better fit to the data, we further analysed the data by
fitting models that need be neither asymmetric nor single peak. We
found that any mathematical model that permits an increase in
NGF population after the peak at 18–22 weeks has a markedly
inferior fit compared to the best-fitting ADC model (Figure 3).
Estimated NGF Population by Age
If menopause is defined as a population of less than one thou-
sand (in line with Faddy & Gosden [2]), the model predicts age of
menopause as 49.6 (95% CI 47.9–51.2) years, with a 95% pre-
diction interval of 38.7–60.0 years (Figure 4). Our model gives a
maximum mean NGF population of 300,000 per ovary (95% CI
225,000–390,000), occurring at 18–22 weeks post-conception, with
a 95% prediction interval (PI) of 35,000–2,534,000 NGFs. Figure 4
gives values for NGF populations at illustrative ages, together with
the corresponding 95% prediction intervals. Women with an
average age of menopause will have around 295,000 NGFs pre-
sent at birth per ovary, with women destined to have an earlier
Figure 1. The model that best fits the histological data. The best model for the establishment of the NGF population after conception, and the
subsequent decline until age at menopause is described by an ADC model with parameters a=5.56 (95% CI 5.38–5.74), b=25.6 (95% CI 24.9–26.4),
c=52.7 (95% CI 51.1–54.2), d =0.074 (95% CI 0.062–0.085), and e=24.5 (95% CI 20.4–28.6). Our model has correlation coefficient r2 =0.81, fit standard
error=0.46 and F-value=364. The figure shows the dataset (n=325), the model, the 95% prediction limits of the model, and the 95% confidence
interval for the model. The horizontal axis denotes age in months up to birth at age zero, and age in years from birth to 51 years.
doi:10.1371/journal.pone.0008772.g001
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population after conception, and the subsequent decline until 25 years of age is described by an ADC model with parameters a=5.79 (95% CI 5.03–
6.55), b=28.0 (95% CI 15.8–40.2), c=57.4 (95% CI 33.1–81.8), d =0.074 (95% CI 0.067–0.081), and e=34.3 (95% CI 24.2–72.8). This model has
correlation coefficient r2 =0.95, fit standard error=0.29 and F-value=585. This figure shows the dataset (n=126), the model, the 95% prediction
limits of the model, and the 95% confidence interval for the model. The horizontal axis denotes age in months up to birth at age zero, and age in
years from birth to 25 years.
doi:10.1371/journal.pone.0008772.g002
Figure 3. The highest ranked model that allows growth after the initial peak. The highest-ranked non-peak model returned by TableCurve
is a polynomial given by log10 NGF ðÞ ~c1   age20zc2   age19z   zc19   age2zc20   agezc21. Compared to the ADC model for the same data, the
model has lower correlation coefficient, higher fit standard error, and lower F-statistic. All other TableCurve models that allow multiple peaks have an
inferior fit to the data.
doi:10.1371/journal.pone.0008772.g003
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women having over 2.5 million NGFs per ovary at birth.
We describe the percentage of the NGF population remaining
for a given age for women whose ovarian reserve is established and
declines in line with our model (Figure 5). We estimate that for
95% of women by the age of 30 years only 12% of their maximum
pre-birth NGF population is present and by the age of 40 years
only 3% remains. The hypothesis that early (respectively late)
menopause is related to low (respectively high) peak population at
18–22 weeks post conception is illustrated in Figure 6.
Rates of NGF Recruitment towards Maturation
To investigate the number of NGFs recruited towards
maturation and ovulation or apoptosis each month we have
solved our model to show (Figure 7a) that the maximum
recruitment of 880 NGFs per month occurs at 14 years 2 months
for the average age at menopause woman. While the maximum
rate of recruitment varies hugely, from around 100 NGFs per
month (Figure 7b) to over 7,500 NGFs per month (Figure 7c) for
women with an early or late menopause respectively, the rate of
NGF recruitment increases to a plateau at just over 14 years and
then decreases for women in general irrespective of how many
NGFs were established by birth.
Discussion
In this study we have identified the first model of human
ovarian reserve from conception to menopause that best fits the
combined histological evidence. This model allows us to estimate
the number of NGFs present in the ovary at any given age,
suggests that 81% of the variance in NGF populations is due to age
alone, and shows that the rate of NGF recruitment increases from
birth to age 14 years then declines with age until menopause.
Further analysis demonstrated that 95% of the NGF population
variation is due to age alone for ages up to 25 years. The
remaining 5% is due to factors other than age e.g. smoking, BMI,
parity and stress. We can speculate that as chronological age
increases, factors other than age become more important in
determining the rate at which NGFs are lost through apoptosis.
We have made two major assumptions in our study. Firstly, that
the results of the eight histological studies that have estimated the
total number of NGFs per human ovary are comparable. The
definition of a NGF is identical in six of the studies and similar in
the remaining two studies. The counting techniques all used a
variation of the technique first described by Block [8]. Our
assumption is in line with that of Faddy and Gosden who also
assumed histological studies to be comparable when deriving a
model for ovarian reserve from birth that also took average age at
menopause into account [2]. The differences between their 1996
study and our study are that we have used more histological data–
including for the first time prenatal data–and that we use known
ranges of age at menopause as a check on the validity of our
model, rather than a contributing factor. In the eight reported
studies, the majority of younger samples were from autopsy and
many of the older subjects had undergone surgical oophorectomy.
It is possible that this difference in the source of the ovarian
samples influences our finding that factors other than age become
more important in older women. Other studies, and previously
reported models, of ovarian reserve have not made a distinction in
the reported source of the material; in particular the Hansen et al.
Figure 4. Illustrative examples. This figure gives illustrative examples of NGF populations predicted by our model. At ages 20 weeks, birth, 13
years, 25 years and 35 years the average NGF population is given, together with the respective 95% prediction intervals. The predicted average age at
menopause (49.6 years) is also shown, together with the 95% prediction interval.
doi:10.1371/journal.pone.0008772.g004
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subjects into a single dataset.
Our second assumption is that the peak number of NGFs at 18–
22 weeks gestation defines age at menopause for the individual
woman, with early menopause women having low peak popula-
tions and late menopause women having high peak populations.
The data on the number of NGFs in the ovary is cross-sectional:
there is no longitudinal data available and in the absence of a non-
invasive test to count NGFs in the individual woman this data is
likely to remain unobtainable. Considered together the wide
variation at age at menopause and wide variation of peak
population of NGFs are suggestive but not conclusive evidence for
this assumption to be tenable.
Since the publications by Johnson et al. [3,4] there has been
lively scientific debate around the widely held concept that a non-
renewing oocyte reserve is laid down in the ovaries at birth, and
that neo-oogenesis does not occur in adult life [6]. Johnson and
Tilly have argued that their experiments in the adult female mouse
have demonstrated conclusively that neo-oogenesis continues in
adulthood. They have proposed that the source of postnatal oocyte
production is from germline stem cells in the bone marrow, which
are transported in the peripheral circulation as germline
progenitor cells to arrive in the adult ovary [4]. The recent report
showing isolation and culture of germline stem cells from adult
mouse ovaries [5], which restored fertility after injection into
infertile mice, provides further evidence to support the presence of
germ line stem cells in mammalian ovaries. Our analysis of the
available histological data demonstrates that any mathematical
model that permits an increase in NGF population after the peak
at 18–22 weeks has a markedly inferior fit compared to the best-
fitting asymmetric peak functions. While the emerging evidence
strongly supports the existence of germ stem cells within adult
mouse ovaries [7], our model provides no supporting evidence of
neo-oogenesis in normal human physiological ageing.
We have described the percentage of the NGF population
remaining for a given age for all women whose ovarian reserve is
established and declines in line with our model (Figure 5). If we
assume that a high initial NGF population is associated with late
menopause, and that a low peak NGF population is associated
with early menopause, then these percentages apply to 95% of all
women. It is important to note that we have shown that by the age
of 30 years the percentage NGF population is already 12% of the
initial reserve and only 3% of the reserve remains at 40 years of
age. A recent study has shown that most women underestimate the
extent to which age affects their ability to conceive naturally [16].
Our finding that the rate of NGF recruitment increases to a
plateau at just over 14 years and then decreases in all women
irrespective of how many NGFs were established by birth is highly
unlikely to be explained by coincidence. From the first
comprehensive model of NGF decline from birth [2] we can
calculate that the maximum NGF recruitment occurs at birth (data
not shown). However, this model was not only based on goodness
of fit to histological data, but it also included adjustments to take
known distribution of ages at menopause into account. A more
recent model of decline from birth is based entirely on fitting to
histological data [13]. For this model we calculate that the
maximum recruitment of NGFs to maturation occurs at 18 years
11 months (data not shown).
In western society the average age of menarche is around 13
years [17], with early breast development appearing around age
Figure 5. Percentage of ovarian reserve related to increasing age. The curve describes the percentage of ovarian reserve remaining at ages
from birth to 55 years, based on the ADC model. 100% is taken to be the maximum ovarian reserve, occurring at 18–22 weeks post-conception. The
percentages apply to all women whose ovarian reserve declines in line with our model (i.e. late and early menopause are associated with high and
low peak NGF populations, respectively). We estimate that for 95% of women by the age of 30 years only 12% of their maximum pre-birth NGF
population is present and by the age of 40 years only 3% remains.
doi:10.1371/journal.pone.0008772.g005
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ovulation heralds a slowing in the rate of NGF recruitment. Our
findings suggest that both endocrine and paracrine factors may be
important in the slowing and subsequent decline in the rate of
NGF recruitment. An important candidate is anti-Mu ¨llerian
hormone (AMH), a member of the transforming growth factor-
beta (TGF-b) superfamily of growth factors [18]. They are
produced by ovarian granulosa cells and oocytes in a develop-
mental, stage-related manner and function as intra-ovarian
regulators of folliculogenesis. There is good evidence that AMH
from granulosa cells of pre-antral or antral follicles exerts a
negative inhibitory influence on the primordial to primary follicle
transition [19]. Furthermore AMH has been proposed as an
indirect marker of ovarian reserve in post-pubertal women [19].
Until the onset of puberty (characterised by the switching on of the
hypothalamic-pituitary axis and the pulsatile secretion of the
gonadotophins FSH and LH) follicular maturation rarely
progresses beyond the pre-antral stage. The presence of the
pulsatile secretion of FSH and LH at puberty promotes follicular
maturation to the antral stage and beyond. There is however
incomplete data on AMH levels in pre-pubertal girls in the
literature: AMH is undetectable before birth [20] and is detectable
at low levels in infants [21]. The explanation for our finding that
the rate of NGF recruitment increases until the onset of puberty,
levels off at around 14 years of age, and then declines to the
menopause remains unclear. It is interesting to speculate that
AMH levels which are undetectable at birth may rise at puberty
with the establishment of regular ovulatory cycles and be
responsible for the slowing of the rate of NGF recruitment that
occurs at puberty.
Can a more complete understanding of the establishment and
decline of the non-renewing pool of NGFs help us to assess ovarian
reserve for the individual woman? Several candidate markers for
the assessment of ovarian reserve in the individual woman have
been suggested including FSH, Inhibin B, AMH, and antral
follicle counts and ovarian volume by transvaginal ultrasound
[22,23]. We have previously reported a striking correlation
between ovarian volume and NGF population using an earlier
model [24]. However the measurement of ovarian volume by
transvaginal ultrasound is imprecise, particularly at the lower end
of the range [25]. It is likely that a better understanding of NGF
establishment and decline will improve our ability to assess ovarian
reserve for the individual woman. One immediate application of
our model is to better understand the effect of chemotherapy and
radiotherapy on the human ovary. Using a model based on less
complete histological data, we estimated the radiosensitivity of the
human oocyte [26] and were subsequently able to estimate the
effective sterilising dose of radiotherapy at a given age for the
individual woman [27]. Knowledge of the dose of radiotherapy
and age at which it is delivered provides an important opportunity
for accurate counselling of women receiving cancer treatment and
will help us to predict which women are at high risk of premature
menopause and who may therefore benefit from ovarian
cryopreservation [28].
We have described and illustrated a model of human ovarian
reserve from conception to menopause that best fits the combined
Figure 6. A hypothetical link between ovarian reserve and age at menopause. This figure describes the hypothesis that individual age at
menopause is determined by the peak NGF population established at around 20 weeks post-conception. The central curve is the ADC model
described in Figures 1 and 4. Above and below are the hypothetical curves for an ovary having log-adjusted peak population varying from the
average case by one half, one, one and a half, and two standard deviations. Under this hypothesis, a variation by, for example, one standard deviation
in the initial peak population results in a one standard deviation from the average age at menopause.
doi:10.1371/journal.pone.0008772.g006
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population to a five-parameter asymmetric double Gaussian
cumulative (ADC) curve (r2 =0.81). When restricted to ages
below 26 years, the ADC curve has r2 =0.95. We estimate that for
95% of women by the age of 30 years only 12% of their maximum
pre-birth NGF population is present and by the age of 40 years
only 3% remains. Furthermore, we found that the rate of NGF
recruitment towards maturation for most women increases from
birth until approximately age 14 years then decreases towards the
menopause. An increased understanding of the dynamics of
human ovarian reserve will provide a more scientific basis for
fertility counselling for both healthy women and those who have
survived gonadotoxic cancer treatments.
Methods
Histological Studies of NGF Populations
Data were taken from all eight known published quantitative
histological studies of the human ovary (Tables 1 and 2). In all
eight studies the definition of a NGF is similar. For studies
2,4,5,6,7 & 8 the definition of a NGF is according to the
morphological criteria of Block and Gougeon [8,11]: an NGF was
counted when a clearly defined oocyte nucleolus was present
within the optical dissector counting frame. In studies 1 & 3, fetal
ovary studies, an NGF was defined as being an oocyte surrounded
by a single layer of granulosa cells. Each of these studies used a
variation on the technique developed by Block to estimate the
NGF population of an ovary [8]. Ovaries are sectioned and some
of the sections stained and photographed. A mean NGF volume is
calculated from a sample image and used throughout all
subsequent calculations. The photographs are analysed by hand,
with the number of NGFs appearing in the photograph being
counted. By assuming an even distribution throughout the ovary,
the population of the samples is integrated into an estimated
population for the entire ovary. The studies differ in the stain used,
the number of samples chosen, the method of counting, and the
mathematical formula used to obtain the estimated population
from the sample populations. Some ovaries were obtained at
autopsy and some after elective surgical oophorectomy. Older
subjects were more likely to have undergone surgical oophorec-
tomy. No standard error has been calculated for such studies, as
the exact number of NGFs in a specific ovary has not been
Figure 7. Rates of NGF recruitment towards maturation. Each sub-figure describes the absolute number of NGFs recruited per month, for ages
from birth to 55 years, based on population decline predicted by the ADC model. Figure 7 (a) - red curve - denotes recruitment for individuals whose
decline is in line with the average age at menopause; maximum recruitment of 880 follicles per month occurs at 14 years 2 months. Figure 7 (b) -
green curve - denotes recruitment for individuals whose decline is in line with early age at menopause (the lower 95% prediction limit of the model);
maximum recruitment of 104 follicles per month occurs at 14 years 2 months. Figure 7 (c) - yellow curve - denote recruitment in line with late age at
menopause (the upper 95% prediction limit of the model); maximum recruitment of 7,520 follicles per month occurs at 14 years 2 months.
doi:10.1371/journal.pone.0008772.g007
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and enforced a zero population at conception.
Mathematical Models
We fitted 20 asymmetric peak models to the data set, using
TableCurve-2D (Systat Software Inc., San Jose, California, USA),
and ranked by r2 correlation coefficient. Each model defines a
generic type of curve and has parameters, which, when
instantiated gives a specific curve of that type. For each type of
curve, we calculated values for the parameters that maximise the
r2 for that model. The 20 models supplied by TableCurve are
those that are commonly reported in the scientific literature as
models of datasets that rise and fall such as pharmacodymanics,
cell populations and electromagnetic signals. The Levenberg-
Marquardt non-linear curve fitting algorithm was used, with
convergence to 15 significant figures in r2 after a maximum of
10,000 iterations. We performed the same analysis on the
datapoints associated with an age of 25 years or under. File S1
contains the dataset, the model ranking, the output used to
prepare Figures 1 and 2, and the statistics associated with the
highest-ranked model.
To avoid selection bias, we randomly removed 50 datapoints 61
times and re-fitted the models, calculating the mean and standard
deviations of the r2 coefficients obtained for each model. We then
compared the mean r2 obtained for the two highest ranked models
for a statistically significant difference. File S2 contains statistics
regarding the correlation coefficient for the models obtained in this
way, together with output for the test for a statistically significant
difference of the two highest means. To further avoid selection bias
from our initial choice of models, and to allow the possibility of
more than one peak (i.e. to allow models involving regeneration of
ovarian reserve), we fitted all 266 models supplied by TableCurve,
again ranking by r2. The highest ranked model was used as the
basis for further calculations. Under the modelling assumption
that, in general, a high (versus low) established population results
in a late (versus early) menopause, we calculated the percentage of
NGF pool at given ages, and the absolute monthly loss of germ
cells from birth until age 55.
Calculation of Recruitment Rates
To calculate the rates of recruitment of NGFs towards
maturation we solved the equations describing the early, late
and average menopause models for all months from birth to
menopause. The absolute numbers of NGFs recruited were then
given by the differences in successive monthly totals.
Supporting Information
File S1 This file contains (1) a plot of the ADC model that best
fits the histological data, (2) full statistics for the model, (3) a plot of
the residuals, (4) the dataset with values for the model, the
residuals, the 95% CI for the model and the 95% prediction
interval, (5) details of the iterations taken to obtain the model, and
(6) the ranking of the peak functions as fitted to the dataset.
Found at: doi:10.1371/journal.pone.0008772.s001 (0.18 MB
PDF)
File S2 It may have been a chance result that the ADC
performed well on the 325 datapoints selected, and that another
model would perform better, in general, on similar datasets. The
additional file contains details of the testing of this hypothesis, and
shows that the ADC mean r
2 was statistically significantly higher
than any other peak model (p=0:0065).
Found at: doi:10.1371/journal.pone.0008772.s002 (0.05 MB
PDF)
Table 1. The eight quantitative histological studies forming
the combined dataset.
Study Statistics
Number First
author
Year No.
ovaries
Min.
age
Max.
age
Median
age
1 Bendsen 2006 11 20.6 20.6 20.6
2 Baker 1963 11 20.6 7.0 20.2
3 Forabosco 2007 15 20.5 0.5 20.3
4 Block 1953 19 20.2 0.0 0.0
5 Hansen 2008 122 0.1 51.0 38.0
6 Block 1951 86 6.0 44.0 28.0
7 Gougeon 1987 52 25.0 46.0 39.5
8 Richardson 1987 9 45.0 51.0 46.0
Overall 325 20.6 51.0 32.0
All ages are in years; the year column refers to the year of publication.
doi:10.1371/journal.pone.0008772.t001
Table 2. The eight quantitative histological studies of NGF population summarised by ovarian age.
Study Ovaries per range of ages
No. First author < 0 0–5 5–10 10–15 15–20 20–25 25–30 30–35 35–40 40–45 45–51
1 B e n d s e n 1 100000000 0 0
2 Baker 5 5 1 0 00000 0 0
3 F o r a b o s c o 1 410000000 0 0
4 B l o c k 5 1 4 0000000 0 0
5 H a n s e n 0 6348881 2 2 22 61 5
6 Block 0 0 10 8 12 8 12 26 10 10 0
7 Gougeon 0 0 0 0 03791 01 76
8 R i c h a r d s o n 0 00000000 2 7
Overall 35 26 14 12 20 19 27 47 42 55 28
Prenatal ovaries are listed in the v 0 column.
doi:10.1371/journal.pone.0008772.t002
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